May 22, 2017 / 10:51 PM / 6 months ago

BRIEF-Taro reports qtrly EPS $2.05

May 22 (Reuters) - Taro Pharmaceutical Industries Ltd

* Taro provides results for year ended March 31, 2017

* Q4 sales $196.4 million

* Qtrly earnings per share $2.05 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below